Lower health care utilization was shown in patients with chronic rhinosinusitis, with and without nasal polyps, who had steroid-eluting implants vs those who did not in the 18 months following ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...
MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced the results of a ...
Maxillary sinus floor elevation and augmentation is a surgical procedure developed to increase bone volume in the atrophic posterior maxilla, thereby facilitating the precise placement of dental ...
VS3 Medical announced the first patients enrolled in first-in-human study evaluating VS3 Medical™ Stent System for symptomatic venous sinus stenosis.
Steroid-eluting implants inserted during or after sinus surgery may benefit patients with chronic sinusitis with or without nasal polyps, including those who can't tolerate oral steroids, a consensus ...
Mani Zadeh, MD, an otolaryngologist at La Peer Health Systems who practices in Beverly Hills, is among the first in the United States to use the PROPEL device to perform sinus implants on an ...
San Jose, California Wednesday, March 11, 2026, 17:00 Hrs [IST] ...
MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results